Synergo + MMC

DEVICE2 trials

Sponsors

Medical Enterprises Europe B.V.

Conditions

Malignant Tumor of Urinary BladderNeoplasmsNeoplasms by SiteUrinary Bladder CancerUrinary Bladder DiseasesUrinary Bladder NeoplasmsUrogenital NeoplasmsUrologic Diseases

Phase 3

Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer

TerminatedNCT00384891

Medical Enterprises Europe B.V.Malignant Tumor of Urinary Bladder, Neoplasms, Neoplasms by Site +5

Start: 2002-02-28End: 2013-12-31Updated: 2014-10-07

SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I

WithdrawnNCT02254915

Medical Enterprises Europe B.V.Neoplasms, Neoplasms by Site, Urinary Bladder Diseases +4

Updated: 2015-04-01

Related Papers

Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer.

2016-01-20159 citations